Klebsiella spp. are commensals of the human microbiota, and a leading cause of opportunistic nosocomial infections. The incidence of multidrug resistant (MDR) strains of Klebsiella pneumoniae causing serious infections is increasing, and Klebsiella oxytoca is an emerging pathogen. Alternative strategies to tackle infections caused by these bacteria are required as strains become resistant to last-resort antibiotics such as colistin. Bacteriophages (phages) are viruses that can infect and kill bacteria. They and their gene products are now being considered as alternatives or adjuncts to antimicrobial therapies. Several in vitro and in vivo studies have shown the potential for lytic phages to combat MDR K. pneumoniae infections. Ready access to cheap sequencing technologies has led to a large increase in the number of genomes available for Klebsiella-infecting phages, with these phages being heterogeneous at the whole-genome level. This review summarizes our current knowledge on phages of Klebsiella spp. and highlights technological and biological issues relevant to the development of phage-based therapies targeting these bacteria.
This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
World Health Organization Global antimicrobial resistance surveillance system (glass) report. early implementation 2017-2018; 2018
ChongY,
YakushijiH,
ItoY,
KamimuraT.
Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. Eur J Clin Microbiol Infect Dis2011; 30:83–87 [View Article]
KhanE,
SchneidersT,
ZafarA,
AzizE,
ParekhA et al. Emergence of CTX-M Group 1-ESBL producing Klebsiella pneumonia from a tertiary care centre in Karachi, Pakistan. J Infect Dev Ctries2010; 4:472–476 [View Article]
ValenzaG,
NickelS,
PfeiferY,
EllerC,
KrupaE et al. Extended-spectrum-β-lactamase-producing Escherichia coli as intestinal colonizers in the German community. Antimicrob Agents Chemother2014; 58:1228–1230 [View Article]
GrundmannH,
GlasnerC,
AlbigerB,
AanensenDM,
TomlinsonCT et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis2017; 17:153–163 [View Article]
PotronA,
PoirelL,
RondinaudE,
NordmannP.
Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill2013; 18:20549–22 [View Article]
JohnsonAP,
WoodfordN.
Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol2013; 62:499–513 [View Article]
GlasnerC,
AlbigerB,
BuistG,
Tambić AndraševićA,
CantónR et al. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Eurosurveillance2013; 18: [View Article]
DavidS,
ReuterS,
HarrisSR,
GlasnerC,
FeltwellT et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat Microbiol20191–11
MoradigaravandD,
MartinV,
PeacockSJ,
ParkhillJ.
Population structure of multidrug-resistant Klebsiella oxytoca within hospitals across the United Kingdom and ireland identifies sharing of virulence and resistance genes with K. pneumoniae
. Genome Biol Evol2017; 9:574–584 [View Article]
EadesC,
DaviesF,
DonaldsonH,
HopkinsK,
HillR et al. GES-5 carpabapenemase-producing Klebsiella oxytoca causing clinical infection in a UK haematopoetic stem cell transplantation unit.
LiuP,
LiX,
LuoM,
XuX,
SuK et al. Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-Analysis. Microbial Drug Resistance2018; 24:190–198 [View Article]
NouvenneA,
TicinesiA,
LauretaniF,
MaggioM,
LippiG et al. Comorbidities and disease severity as risk factors for carbapenem-resistant Klebsiella pneumoniae colonization: report of an experience in an internal medicine unit. PLoS One2014; 9:e110001 [View Article]
YuJ,
TanK,
RongZ,
WangY,
ChenZ et al. Nosocomial outbreak of KPC-2- and NDM-1-producing Klebsiella pneumoniae in a neonatal ward: a retrospective study. BMC Infect Dis2016; 16:563 [View Article]
LeeC-H,
ChenI-L,
ChuahS-K,
TaiW-C,
ChangC-C et al. Impact of glycemic control on capsular polysaccharide biosynthesis and opsonophagocytosis of Klebsiella pneumoniae: implications for invasive syndrome in patients with diabetes mellitus. Virulence2016; 7:770–778 [View Article]
SilvaN,
OliveiraM,
BandeiraAC,
BritesC.
Risk factors for infection by extended-spectrum beta-lactamase producing Klebsiella pneumoniae in a tertiary hospital in Salvador, Brazil. Brazilian Journal of Infectious Diseases2006; 10:191–193 [View Article]
Zollner‐SchwetzI,
HögenauerC,
JoainigM,
WeberhoferP,
GorkiewiczG et al. Role of Klebsiella oxytoca in Antibiotic‐Associated Diarrhea. Clinical Infectious Diseases2008; 47:e74–e78 [View Article]
HerzogKAT,
SchneditzG,
LeitnerE,
FeierlG,
HoffmannKM et al. Genotypes of Klebsiella oxytoca isolates from patients with nosocomial pneumonia are distinct from those of isolates from patients with antibiotic-associated hemorrhagic colitis. J Clin Microbiol2014; 52:1607–1616 [View Article]
CortésG et al. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun2002; 70:2583–2590 [View Article]
YoshidaK,
YamaguchiK,
UchidaKou,
TsujimotoS,
MatsumotoT et al. Role of bacterial capsule in local and systemic inflammatory responses of mice during pulmonary infection with Klebsiella pneumoniae
. J Med Microbiol2000; 49:1003–1010 [View Article]
StruveC,
BojerM,
KrogfeltKA.
Characterization of Klebsiella pneumoniae type 1 fimbriae by detection of phase variation during colonization and infection and impact on virulence. Infect Immun2008; 76:4055–4065 [View Article]
StruveC,
BojerM,
KrogfeltKA.
Identification of a conserved chromosomal region encoding Klebsiella pneumoniae type 1 and type 3 fimbriae and assessment of the role of fimbriae in pathogenicity. Infect Immun2009; 77:5016–5024 [View Article]
HoltKE,
WertheimH,
ZadoksRN,
BakerS,
WhitehouseCA et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A2015; 112:E3574–E3581 [View Article]
MerlaC,
RodriguesC,
PassetV,
CorbellaM,
ThorpeHA et al. Description of Klebsiella spallanzanii sp. nov. and of Klebsiella pasteurii sp. nov. Front Microbiol2019; 10:2360 [View Article]
On an invisible microbe antagonistic to dysentery bacilli . Note by M. F. d’Herelle, presented by M. Roux. Comptes Rendus Academie des Sciences 1917; 165:373–5. Bacteriophage2011; 1:3–5 [View Article]
WitteboleX,
De RoockS,
OpalSM.
A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence2014; 5:226–235 [View Article]
SiringanP,
ConnertonPL,
CummingsNJ,
ConnertonIF.
Alternative bacteriophage life cycles: the carrier state of Campylobacter jejuni
. Open Biol2014; 4:130200 [View Article]
ChhibberS,
NagD,
BansalS.
Inhibiting biofilm formation by Klebsiella pneumoniae B5055 using an iron antagonizing molecule and a bacteriophage. BMC Microbiol2013; 13:174 [View Article]
JamalM,
HussainT,
DasCR,
AndleebS.
Characterization of Siphoviridae phage Z and studying its efficacy against multidrug-resistant Klebsiella pneumoniae planktonic cells and biofilm. J Med Microbiol2015; 64:454–462 [View Article]
D’AndreaMM,
MarmoP,
Henrici De AngelisL,
PalmieriM,
CiacciN et al. φBO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineage. Sci Rep2017; 7:2614 [View Article] [View Article]
YosefI,
GorenMG,
GlobusR,
Molshanski-MorS,
QimronU.
Extending the host range of bacteriophage particles for DNA transduction. Mol Cell2017; 66:721–728 [View Article]
KumariS,
HarjaiK,
ChhibberS.
Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice. J Microbiol Biotechnol2010; 20:935–941 [View Article]
CaoF,
WangX,
WangL,
LiZ,
CheJ et al. Evaluation of the Efficacy of a Bacteriophage in the Treatment of Pneumonia Induced by Multidrug Resistance Klebsiella pneumoniae in Mice. Biomed Res Int2015; 2015:7529309 [View Article]
VinodkumarCS,
NeelagundYF,
KalsurmathS.
Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae
. J Commun Dis2005; 37:18–29
KumariS,
HarjaiK,
ChhibberS.
Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples. Folia Microbiol2010; 55:221–227 [View Article]
KumariS,
HarjaiK,
ChhibberS.
Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. J Med Microbiol2011; 60:205–210 [View Article]
HsuBB,
GibsonTE,
YeliseyevV,
LiuQ,
LyonL et al. Dynamic modulation of the gut microbiota and metabolome by bacteriophages in a mouse model. Cell Host Microbe2019; 25:803–814 [View Article]
ChadhaP,
KatareOP,
ChhibberS.
In vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB/c mice. Microb Pathog2016; 99:68–77 [View Article]
KutterE,
De VosD,
GvasaliaG,
AlavidzeZ,
GogokhiaL et al. Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol2010; 11:69–86 [View Article]
DebarbieuxL,
PirnayJ-P,
VerbekenG,
De VosD,
MerabishviliM et al. A bacteriophage journey at the European medicines Agency. FEMS Microbiol Lett2016; 363:fnv225 [View Article]
RhoadsDD,
WolcottRD,
KuskowskiMA,
WolcottBM,
WardLS et al. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care2009; 18:237–243 [View Article]
WrightA,
HawkinsCH,
AnggårdEE,
HarperDR.
A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol Off J ENT-UK Off J Neth Soc Oto-Rhino-Laryngol Cervico-Facial Surg2009; 34:349–357
KuipersS,
RuthMM,
MientjesM,
de SévauxRGL,
van IngenJ.
Successful treatment of chronic relapsing urinary tract infection with bacteriophages in a renal transplant recipient - a Dutch case report. Antimicrob Agents Chemother
CorbellinoM,
KiefferN,
KutateladzeM,
BalarjishviliN,
LeshkasheliL et al. Eradication of a multi-drug resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom-made, lytic bacteriophage preparation. Clin Infect Dis Off Publ Infect Dis Soc Am
.
PatelDR,
BhartiyaSK,
KumarR,
ShuklaVK,
NathG.
Use of customized bacteriophages in the treatment of chronic nonhealing wounds: a prospective study. Int J Low Extrem Wounds2019; 1534734619881076:
PyraA,
BrzozowskaE,
PawlikK,
GamianA,
DauterM et al. Tail tubular protein A: a dual-function tail protein of Klebsiella pneumoniae bacteriophage KP32. Sci Rep2017; 7:2223 [View Article]
Majkowska-SkrobekG,
ŁątkaA,
BerisioR,
MaciejewskaB,
SquegliaF et al. Capsule-targeting depolymerase, derived from Klebsiella KP36 phage, as a tool for the development of anti-virulent strategy. Viruses2016; 8:324 [View Article]
MaciejewskaB,
RoszniowskiB,
EspaillatA,
Kęsik-SzelochA,
Majkowska-SkrobekG et al.Klebsiella phages representing a novel clade of viruses with an unknown DNA modification and biotechnologically interesting enzymes. Appl Microbiol Biotechnol2017; 101:673–684 [View Article]
BriersY,
WalmaghM,
GrymonprezB,
BieblM,
PirnayJ-P et al. Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa
. Antimicrob Agents Chemother2014; 58:3774–3784 [View Article]
ColavecchioA,
CadieuxB,
LoA,
GoodridgeLD.
Bacteriophages contribute to the spread of antibiotic resistance genes among foodborne pathogens of the Enterobacteriaceae family – a review. Front Microbiol2017; 8:1108 [View Article]
European Commission Final Report Summary - PHAGOBURN (Evaluation of phage therapy for the treatment of Escherichia coli and Pseudomonas aeruginosa burn wound infections (Phase I-II clinical trial)); 2017
JaultP,
LeclercT,
JennesS,
PirnayJP,
QueY-A et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis2019; 19:35–45 [View Article]
ConnorTR,
LomanNJ,
ThompsonS,
SmithA,
SouthgateJ et al. CLIMB (the cloud infrastructure for microbial bioinformatics): an online resource for the medical microbiology community. Microb Genomics2016; 2:e000086 [View Article]
HsuC-R,
LinT-L,
PanY-J,
HsiehP-F,
WangJ-T.
Isolation of a bacteriophage specific for a new capsular type of Klebsiella pneumoniae and characterization of its polysaccharide depolymerase. PLoS One2013; 8:e70092 [View Article]
AleshkinAV,
ErshovaON,
VolozhantsevNV,
SvetochEA,
PopovaAV et al. Phagebiotics in treatment and prophylaxis of healthcare-associated infections. Bacteriophage2016; 6:e1251379 [View Article]
ParkE-A,
KimY-T,
ChoJ-H,
RyuS,
LeeJ-H.
Characterization and genome analysis of novel bacteriophages infecting the opportunistic human pathogens Klebsiella oxytoca and K. pneumoniae
. Arch Virol2017; 162:1129–1139 [View Article]
CiacciN,
D’AndreaM,
MarmoP,
DemattèE,
AmisanoF et al. Characterization of vB_Kpn_F48, a newly discovered lytic bacteriophage for Klebsiella pneumoniae of sequence type 101. Viruses 10:482 [View Article]
KarumidzeN,
KusradzeI,
RigvavaS,
GoderdzishviliM,
RajakumarK et al. Isolation and characterisation of lytic bacteriophages of Klebsiella pneumoniae and Klebsiella oxytoca
. Curr Microbiol2013; 66:251–258 [View Article]
WangC,
LiP,
NiuW,
YuanX,
LiuH et al. Protective and therapeutic application of the depolymerase derived from a novel KN1 genotype of Klebsiella pneumoniae bacteriophage in mice. Res Microbiol2019; 170:156–164 [View Article]
HsiehP-F,
LinH-H,
LinT-L,
ChenY-Y,
WangJ-T.
Two T7-like bacteriophages, K5-2 and K5-4, each encodes two capsule depolymerases: isolation and functional characterization. Sci Rep2017; 7:4624 [View Article]
PanYi‐Jiun,
LinTzu‐Lung,
ChenYi‐Yin,
LaiPeng‐Hsuan,
TsaiYun‐Ting et al. Identification of three podoviruses infecting Klebsiella encoding capsule depolymerases that digest specific capsular types. Microb Biotechnol2019; 12:472–486
TengT,
LiQ,
LiuZ,
LiX,
LiuZ et al. Characterization and genome analysis of novel Klebsiella phage Henu1 with lytic activity against clinical strains of Klebsiella pneumoniae. Arch Virol
ErikssonH,
MaciejewskaB,
LatkaA,
Majkowska-SkrobekG,
HellstrandM et al. A suggested new bacteriophage genus, “Kp34likevirus”, within the Autographivirinae Subfamily of Podoviridae
. Viruses2015; 7:1804–1822 [View Article]
LinT-L,
HsiehP-F,
HuangY-T,
LeeW-C,
TsaiY-T et al. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment. J Infect Dis2014; 210:1734–1744 [View Article]
ShangA,
LiuY,
WangJ,
MoZ,
LiG et al. Complete nucleotide sequence of Klebsiella phage P13 and prediction of an EPS depolymerase gene. Virus Genes2015; 50:118–128 [View Article]
YerushalmyO,
Coppenhagen-GlazerS,
Nir-PazR,
TuomalaH,
SkurnikM et al. Complete genome sequences of Two Klebsiella pneumoniae phages isolated as part of an international effort. Microbiol Resour Announc 8: [View Article]
LuY,
ShiH,
ZhangZ,
HanF,
LiJ et al. Isolation and characterization of a lytic bacteriophage φKp-lyy15 of Klebsiella pneumoniae
. Virol Sin2015; 30:66–68 [View Article]
LiuY,
MiL,
MiZ,
HuangY,
LiP et al. Complete genome sequence of IME207, a novel bacteriophage which can lyse multidrug-resistant Klebsiella pneumoniae and Salmonella
. Genome Announc2016; 4: [View Article]
HoylesL,
MurphyJ,
NeveH,
HellerKJ,
TurtonJF et al.Klebsiella pneumoniae subsp. pneumoniae –bacteriophage combination from the caecal effluent of a healthy woman. PeerJ2015; 3:e1061 [View Article]
CaiR,
WangZ,
WangG,
ZhangH,
ChengM et al. Biological properties and genomics analysis of vB_KpnS_GH-K3, a Klebsiella phage with a putative depolymerase-like protein. Virus Genes2019; 55:696–706 [View Article]
BrownTL,
PetrovskiS,
HoyleD,
ChanHT,
LockP et al. Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca
. PLoS One2017; 12:e0183510 [View Article]